跳至主要内容
临床试验/NL-OMON45191
NL-OMON45191招募中不适用

Inhibition of Neointimal hyperplasia with Paclitaxel-eluting balloon angioplasty in haemodialysis shunts. A multicenter randomized clinical trial of paclitaxel drug-eluting balloon (DEB) versus standard percutaneous transluminal angioplasty (PTA) to reduce restenosis in patients with haemodialysis access stenoses. - APERTO Trial

Cardionovum GmbH0 个研究点目标入组 118 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
118

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • •Subjects with stenosis in native haemodialysis fistulas or prosthetic haemodialysis grafts on the arm, AND
  • •that were previously well functioning, AND
  • •that now present with clinical abnormalities indicating decreased functioning, as defined in the NKF-DOQIcprotocol criteria (National Kidney Foundation 2000)

排除标准

  • •Unable to provide informed consent
  • •In-stent restenose (that is: a shunt that has been treated previously with a metallic stent)

研究者

相似试验

已完成
不适用
Prevention of in-stent neointimal proliferation by Pioglitazone StudyType 2 diabetic patients with ischemic heart disease
JPRN-UMIN000000485Bell Land General Hospital100
已完成
不适用
Phase II study of Paclitaxel and Nedaplatin for previously untreated patients with advanced squamous cell lung cancer.Squamous cell lung cancer
JPRN-UMIN000008872Tochigi Cancer Center17
进行中(未招募)
不适用
Drug-Eluting Balloon Angioplasty for the Treatment of Hemodialysis Vascular Access Stenosis (DEBAVAS)Dysfunction of Hemodialysis Vascular Access (Fistula and Graft)
NCT02408822Centre Hospitalier Universitaire de Nice52
招募中
2 期
Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases. A single-arm, open-label, phase II trial. Nab-PIPAC TrialPancreatic cancer with peritoneal metastases
2024-518938-81-00Fondazione Policlinico Universitario Agostino Gemelli IRCCS38
进行中(未招募)
1 期
Prevention of Paclitaxel-caused neuropathic pain by intake of Telmisartan in patients with planned Paclitaxel chemotherapy due to ovarian or breast cancer (PrevTel)patients with planned Paclitaxel chemotherapy due to ovarian or breast cancerMedDRA version: 20.0Level: LLTClassification code 10077974Term: Peripheral neuropathic painSystem Organ Class: 100000004852
EUCTR2019-000210-11-DEFraunhofer Gesellschaft for its Fraunhofer Institute for Translational Medicine and Pharmacology ITMP35